Showing results (1021-1030 of 1,160) with videos related to

Sort By:
Pageof 116
Gynecologic Oncology|June 18, 2019
Safety, clinical activity and biomarker assessments of atezolizumab from a Phase I study in advanced/recurrent ovarian and uterine cancersJoyce F Liu, Michael Gordon, Jennifer Veneris, et al.
Blood|October 7, 2025
A Notch trans-activation to cis-inhibition switch underlies hematopoietic stem cell agingFrancesca Matteini, Roshana Thambyrajah, Sara Montserrat-Vazquez, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Evolution of Diagnoses, Survival, and Costs of Oncological Medical Treatment for Non-Small-Cell Lung Cancer over 20 Years in Osona, CataloniaMarta Parera Roig, David Compte Colomé, Gemma Basagaña Colomer, et al.
Cellular and Molecular Life Sciences : CMLS|March 6, 2007
Melatonin biosynthesis in the thymus of humans and ratsM C Naranjo, J M Guerrero, A Rubio, et al.
The Analyst|September 28, 2021
Optimized detection of lung IL-6 via enzymatic liquefaction of low respiratory tract samples: application for managing ventilated patientsAntonio Clemente, Alejandra Alba-Patiño, Giulia Santopolo, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|March 11, 2006
[Correlation of lipid profiles and anthropometric variables with serum lipoprotein(a) levels in childhood]Y Sáez Meabe, M Lafita Bernar, J P Sáez de Lafuente Chivite, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 8, 2021
Association of Proinflammatory Cytokine Levels with Stroke Severity, Infarct Size, and Muscle Strength in the Acute Phase of StrokeAna Carolina Silva Bitencourt, Rodolfo Pessato Timóteo, Rodrigo Bazan, et al.
The Journal of Clinical Investigation|June 21, 2016
The composition of the microbiota modulates allograft rejectionYuk Man Lei, Luqiu Chen, Ying Wang, et al.
Marine Environmental Research|December 18, 2018
Long-term changes on estuarine ciliates linked with modifications on wind patterns and water turbidityM Celeste López-Abbate, Juan-Carlos Molinero, Gerardo M E Perillo, et al.
The Lancet. Oncology|December 2, 2019
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trialPeter Schmid, Hope S Rugo, Sylvia Adams, et al.
Pageof 116